RE:Partnership coming or not? No one believes cancer news…I thought about the selling pressure too, but came to the conclusion that given the highly conservative nature of management, the fact most are remote still, and the fact we analyze every darn clue there is released or not, that I just don't think there is any group of investors that knows a whole lot more than we do about the cancer opportunity. So I discount that someone has ferreted out an aspect of the program to justify the selling.
Now that doesn't at all preclude someone from just determining they don't want to deal with the timeline, or the risk, or they are looking more generally at the cancer space and seeing numerous new technologies looking to tackle the issue; hence, a highly competitive space. Those can easily be reasons to move out, but I don't think it's that there has been a negative signal on the progress of the Phase 1a trial.
On NASH, they're now about 3 months in to a likely 6 to 12 month process. I think we'll have to wait still for any partnership discussions for NASH and, if and when they come about, don't expect a lot of upfront money changing hands.
Dcutter101 wrote: So let's Get NASH going!!!